Skip to content
‹ Back to IndustriesSciences

The Tools Leading The Science Community to New Discoveries

Many of our technological advances are used first by the scientific community. Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example. 3D printers were used by scientists before they entered industry. The internet was created for scientific usage before becoming more generally available to the…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Troy Camplin · · AiAutomationQuantum ComputingScience
Share
The Tools Leading The Science Community to New Discoveries

Key takeaways

01

Many of our technological advances are used first by the scientific community.

02

Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example.

03

3D printers were used by scientists before they entered industry.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Many of our technological advances are used first by the scientific community. Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example. 3D printers were used by scientists before they entered industry. The internet was created for scientific usage before becoming more generally available to the public, especially through the subsequent development of the world wide web.

So, what are scientists using these days?

Artificial Intelligence

One thing scientists are using more and more is artificial intelligence (AI). AI is being used in what is called augmented analytics to better analyze data and to find patterns that may not be as obvious to humans. Human-AI interactions are resulting in new theories and hypotheses to be tested in the lab. It will be interesting to see what happens as people in-turn put the results of those experiments back into the AI for further refinement of those theories and the development of even more testable hypotheses.

The amount of data collected for all things from science to business has entered the zettabyte era (that is sextillion bytes), meaning it is becoming increasingly impossible for humans to deal with it all. Only AI is even remotely capable of handling this amount of data—an amount which is only increasing each and every moment.

Quantum Computers

Machine learning is going to take a quantum leap the moment quantum computers become fully feasible—and that moment is rapidly approaching. Right now, it is well within the realm of scientific research, in no small part because of the problems with cooling such a system, but it is expected that quantum computing will become more widely available in the next several years.

In the meantime, the development of quantum computing itself will provide researchers with more scientific knowledge about quantum physics and how we can use that knowledge to create more powerful computers and AI. After all, we are still working out exactly how quantum computers do their calculations and knowing that will lead to the design of even better quantum computers.

Quantum computers will help scientists fully integrate complex data, better analyze complex systems and processes, and thus help make better pattern predictions for such systems. This will help not only the physical and biological sciences, but also the more complex social and psychological sciences where reductionist methods have proven less than sufficient to help us understand these processes.

Robots

Robotics is another area which will no doubt impact science. The continuing development of more refined movement will allow field scientists to use robots to reach places that might have otherwise been too dangerous for a human, and it will allow scientists in the lab to engage in more precise manipulations of living and physical objects. The development of soft robotics will further open up research possibilities in more difficult-to-reach areas.

Robotic process automation will also help scientists a great deal more. Many lab processes have been automated, but many more can be. This will free scientists up to do more research, to better keep up with the reading and to do more of the mental work of science rather than having to spend quite so much time doing simple repetitive jobs. The more such technology permeates, the more even the small labs at small colleges will be automated, and the more those scientists can contribute.

Technology is transforming science every bit as much as it does business and our personal lives. Usually, the scientists get the first shot at the most recent technological innovations, trying them out and using them to advance our knowledge. It is sometimes hard to imagine what can come out of scientific instruments—who would have expected body imaging from a chemical structure analysis tool? So long as people are free to think and innovate, we will continue to see technological advances emerging out of the lab and into our living rooms.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

TC
Troy Camplin
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Agilent's new 5987A GC/MS takes aim at costly sample reruns

Agilent's new 5987A GC/MS takes aim at costly sample reruns

Agilent’s 5987A GC/MSD adds vendor-claimed up to 25% faster scanning and a wider detector range alongside GC Assist diagnostics tracking 60-plus parameters. Its design focuses on taking injections out of workflows to limit reruns. With helium spot prices reportedly doubling after the March 2026 disruption, avoided reruns can save gas, but EPA criteria checks and ISO/IEC 17025 verification still come first.

  • 01Injection-cutting features can matter most: MassHunter’s simultaneous dSIM/Scan to combine SIM quantitation and library-searchable full scan in one run, and Agilent’s claim of an order-of-magnitude wider dynamic range that could reduce dilution reinjections if it holds up in routine use.
  • 02Onboard diagnostics pay back unevenly. Labs that find faults by failing QC batches stand to gain the most, while labs on comprehensive service contracts may mainly change which contract tier they buy.
  • 03The up-to-40% energy cut applies with the IDP-4 pump, so bid scoring should confirm the quoted configuration before crediting the savings.

Nov 10, 2026

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Adding Genmab's petosemtamab to Keytruda cut head and neck cancer death risk in half

Genmab's petosemtamab, added to Merck's Keytruda, cut the risk of death by 50% in 699 first-line head and neck cancer patients. The trial held regardless of HPV status. Full data will be presented at an upcoming medical meeting.

  • 01In a cancer where median survival runs about 10 to 12 months, adding petosemtamab to Keytruda halved the risk of death at the first interim look.
  • 02The benefit held regardless of HPV status, supporting use in PD-L1-positive patients without separating by HPV status.
  • 03The figure to watch at the full-data presentation is median overall survival in each arm, because the topline release reports only the hazard ratio.

Nov 9, 2026

UCB commits to Veeva Vault CRM platform

UCB commits to Veeva Vault CRM platform

UCB has committed to Veeva Vault CRM, which Veeva’s release presents as an agentic CRM platform to drive unified engagement worldwide. UCB and Veeva executives describe it as a stable foundation for UCB’s commercial strategy, while the AI claims, including the Agentic Call Report, come from Veeva’s product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If it works as described, call reports gain value when analyzed at scale.
  • 03No go-live date or financial terms were disclosed. A go-live date or first-market rollout from UCB would show whether a worldwide migration is moving.

Nov 7, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

TC
Troy Camplin

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512